Quarter Sales Unchanged for Gish Biomedical
- Share via
IRVINE — Gish Biomedical Inc., a medical products company, posted net income of $61,500, or 2 cents a share, for the fiscal first quarter ended Sept. 30, contrasted with a net loss of $84,100, or 3 cents a share, for the corresponding period a year ago. Sales were unchanged at $5.3 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
